RCRichard J. Cornall

Richard J. Cornall

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Richard J. Cornall has a total of 20 co-authors. Here are the top co-authors by number of shared publications:

  • Andrew T. McKie

    Department of Biochemistry and Nutrition Sciences Research Division, King's College London, London, United Kingdom

    1 shared publication
  • Aron Chakera

    School of Medicine and Pharmacology, Sir Charles Gairdner Hospital, The University of Western Australia, 4th Floor G Block, Hospital Avenue, Nedlands, Perth, WA 6009, Australia

    1 shared publication
  • Christopher C. Goodnow

    Garvan Institute of Medical Research, Sydney, Australia

    1 shared publication
  • Dean R. Campagna

    Department of Pathology, Children's Hospital and Harvard Medical School, Boston, MA

    1 shared publication
  • Gladys O. Latunde-Dada

    Department of Biochemistry and Nutrition Sciences Research Division, King's College London, London, United Kingdom

    1 shared publication
  • Guadalupe Villarreal

    Department of Pathology, Children's Hospital and Harvard Medical School, Boston, MA

    1 shared publication

Latest Publications

  • Open Access

    The Phenotype of Circulating Follicular-Helper T Cells in Patients with Rheumatoid Arthritis Defines CD200 as a Potential Therapeutic Target

    by Aron Chakera, Sophia C. Bennett, Olivier Morteau, Paul Bowness, Raashid A. Luqmani, Richard J. Cornall

    Rheumatoid arthritis (RA) is a systemic autoimmune disease primarily affecting synovial joints in which the development of autoantibodies represents a failure of normal tolerance mechanisms, suggesting a role for follicular helper T cells (TFH) in the genesis of autoimmunity. To determine whether quantitative or qualitative abnormalities in the circulatingTFHcell population exist, we analysed by flow cytometry the number and profile of these cells in 35 patients with RA and 15 matched controls. Results were correlated with patient characteristics, including the presence of autoantibodies, disease activity, and treatment with biologic agents. CirculatingTFHcells from patients with RA show significantly increased expression of the immunoglobulin superfamily receptor CD200, with highest levels seen in seropositive patients (P=0.0045) and patients treated with anti-TNFαagents (P=0.0008). This occurs in the absence of any change inTFHnumbers or overt bias towards Th1, Th2, or Th17 phenotypes. CD200 levels did not correlate with DAS28 scores (P=0.887). Although the number of circulatingTFHcells is not altered in the blood of patients with RA, theTFHcells have a distinct phenotype. These differences associateTFHcells with the pathogenesis of RA and support the relevance of the CD200/CD200R signalling pathway as a potential therapeutic target.


  • Open Access

    Identification of a Steap3 endosomal targeting motif essential for normal iron metabolism

    by Teresa Lambe, Robert J. Simpson, Sara Dawson, Tiphaine Bouriez-Jones, Tanya L. Crockford, Michelle Lepherd, Gladys O. Latunde-Dada, Hannah Robinson, Kishor B. Raja, Dean R. Campagna, et al.

    Hereditary forms of iron-deficiency anemia, including animal models, have taught us much about the normal physiologic control of iron metabolism. However, the discovery of new informative mutants is limited by the natural mutation frequency. To address this limitation, we have developed a screen for heritable abnormalities of red blood cell morphology in mice with single-nucleotide changes induced by the chemical mutagen ethylnitrosourea (ENU). We now describe the first strain, fragile-red, with hypochromic microcytic anemia resulting from a Y228H sub-stitution in the ferrireductase Steap3 (Steap3Y288H). Analysis of the Steap3Y288H mutant identifies a conserved motif required for targeting Steap3 to internal compartments and highlights how phenotypic screens linked to mutagenesis can identify new functional variants in erythropoiesis and ascribe function to previously unidentified motifs.